|
⚲
|
| Keyboard |
| Shah Preetam
✚
|
|
|---|---|
| CIK # | 0001787403 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001787403] | |
| 4 | [0001787403] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Shah Preetam | |
| Elicio Therapeutics Inc | |
| K2 Therapeutics Inc | |
| Brainstorm Cell Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Elicio Therapeutics Inc ELTX
Common Stock
|
2026-02-02 | Grant | 24,000 | $0.00 | |
|
Elicio Therapeutics Inc ELTX
Stock Option (Right to Buy) · derivative
|
2026-02-02 | Grant | 47,900 | $0.00 | |
|
Elicio Therapeutics Inc ELTX
Stock Option (Right to Buy) · derivative
|
2025-04-15 | Grant | 191,624 | $0.00 | |
|
K2 Therapeutics Inc CDTX
Employee Stock Option (right to buy) · derivative
|
2024-09-30 | Grant | 130,087 | $0.00 | |
|
K2 Therapeutics Inc CDTX
Employee Stock Option (right to buy) · derivative
|
2024-03-15 | Grant | 217,500 | $0.00 | |
|
K2 Therapeutics Inc CDTX
Common Stock
|
2024-03-15 | Grant | 108,750 | $0.00 | |
|
K2 Therapeutics Inc CDTX
Common Stock
|
2024-03-11 | Sell | 18,931 | $0.67 | 12,684 |
|
K2 Therapeutics Inc CDTX
Employee Stock Option (right to buy) · derivative
|
2023-03-27 | Grant | 180,000 | $0.00 | |
|
K2 Therapeutics Inc CDTX
Common Stock
|
2023-03-27 | Grant | 90,000 | $0.00 | |
|
K2 Therapeutics Inc CDTX
Common Stock
|
2023-03-13 | Sell | 6,648 | $1.53 | 10,171 |
|
K2 Therapeutics Inc CDTX
Common Stock
|
2022-09-19 | Sell | 15,642 | $0.77 | 12,044 |
|
K2 Therapeutics Inc CDTX
Common Stock
|
2022-09-15 | Option exercise | 50,000 | $0.00 | |
|
K2 Therapeutics Inc CDTX
Restricted Stock Unit · derivative
|
2022-09-15 | Option exercise | 50,000 | $0.00 | |
|
K2 Therapeutics Inc CDTX
Common Stock
|
2022-03-31 | Tax withheld | 24,820 | $0.83 | 20,601 |
|
K2 Therapeutics Inc CDTX
Common Stock
|
2022-03-31 | Grant | 66,001 | $0.00 | |
|
K2 Therapeutics Inc CDTX
Common Stock
|
2022-03-31 | Grant | 51,250 | $0.00 | |
|
K2 Therapeutics Inc CDTX
Employee Stock Option (right to buy) · derivative
|
2022-03-31 | Grant | 102,500 | $0.00 | |
|
K2 Therapeutics Inc CDTX
Common Stock
|
2021-11-12 | Buy | 20,000 | $1.54 | 30,800 |
|
K2 Therapeutics Inc CDTX
Restricted Stock Unit · derivative
|
2021-09-01 | Grant | 50,000 | $0.00 | |
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2021-09-01 | Grant | 311,850 | $0.00 | |
| showing 20 of 25 most recent transactions | |||||